Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2010 Apr 13;79(2):400–407. doi: 10.1016/j.ijrobp.2009.10.032

Table 1.

Patient characteristics.

Characteristic Received IORT n=71 (%)
Median age (range) 64 (48–92)
Clinical Staging
 cT1a 2 (2.8%)
 cT1b 18 (25%)
 cT1c 35 (49%)
 cT2 (<3cm) 16 (23%)
 cN0 71 (100%)
Grade
 I 25 (35%)
 II 24 (34%)
 III 22 (31%)
Markers
 ER+ 54 (76%)
 PR+ 50 (70%)
 HER2+ 8 (11%)
 ER+, PR+, HER2− 46 (65%)
  “triple negative” 12 (17%)